Read
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Devastated by tornado
A huge tornado tears through the Oklahoma City suburb of Moore, killing dozens. Slideshow
Nuclear tsunami wall
Safety upgrades designed to prevent a repeat of the Fukushima disaster. Slideshow
Sponsored Links
Novartis withdraws marketing application for Ruvise
LONDON |
LONDON (Reuters) - Swiss drugmaker Novartis has withdrawn a marketing application for its drug Ruvise, designed to treat arterial hypertension, the European Medicines Agency (EMA) said on Thursday.
The drug, known generically imatinib mesilate, was intended for use in adults as add-on therapy for the treatment of pulmonary arterial hypertension (PAH), the drug regulator said in a statement.
EMA reported that Novartis had said that the withdrawal was because it requires additional data to address the regulator's questions relating to its benefit-risk assessment.
The data would not be available within the timeframe allowed in the centralized procedure, it said.
(Reporting by Kate Kelland; Editing by David Goodman)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters